Stock Analysts’ Updated EPS Estimates for April, 17th (ABF, ALB, ASHM, BAC, BREE, CNE, DIA, DWDP, EMN, GKN)

Stock Analysts’ updated eps estimates for Tuesday, April 17th:

Associated British Foods (LON:ABF) had its buy rating reissued by analysts at Shore Capital. The firm currently has a GBX 2,583 ($36.98) target price on the stock.

How to Become a New Pot Stock Millionaire

Albemarle (NYSE:ALB) had its buy rating reissued by analysts at Royal Bank of Canada. They currently have a $113.00 target price on the stock.

Ashmore Group (LON:ASHM) had its add rating reiterated by analysts at Peel Hunt. Peel Hunt currently has a GBX 440 ($6.30) target price on the stock.

Bank of America (NYSE:BAC) had its buy rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $34.00 price target on the stock.

Breedon Group (LON:BREE) had its add rating reiterated by analysts at Peel Hunt. The firm currently has a GBX 92 ($1.32) price target on the stock.

Cairn Energy (LON:CNE) had its overweight rating reaffirmed by analysts at Barclays.

Cairn Energy (LON:CNE) had its buy rating reiterated by analysts at Peel Hunt. The firm currently has a GBX 250 ($3.58) target price on the stock.

Dialight (LON:DIA) had its hold rating reiterated by analysts at Peel Hunt. The firm currently has a GBX 600 ($8.59) target price on the stock.

Dow Chemical (NYSE:DWDP) had its buy rating reissued by analysts at Royal Bank of Canada. They currently have a $85.00 price target on the stock.

Eastman Chemical (NYSE:EMN) had its hold rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $103.00 target price on the stock.

GKN (LON:GKN) was downgraded by analysts at Raymond James Financial to a market perform rating.

HSBC (LON:HSBA) had its neutral rating reissued by analysts at JPMorgan Chase. The firm currently has a GBX 730 ($10.45) price target on the stock.

Independent Oil & Gas (LON:IOG) had its buy rating reiterated by analysts at VSA Capital. They currently have a GBX 72 ($1.03) price target on the stock.

La Jolla Pharmaceutical (NASDAQ:LJPC) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “LA JOLLA PHARMACEUTICAL CO. is engaged in the research and development of therapeutic products for the treatment of autoimmune and inflammatory diseases. “

MAM Software Group (NASDAQ:MAMS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “MAM Software Group, Inc. develops and markets software solutions with the objective to bring competitive advantages and increased profitability to its clients and business partners. The Company is bringing its professional business management systems and e-commerce solutions to the US automotive aftermarket. The Company’s Autopart v20 software is an enterprise management solution for two step parts distributors and jobbers. It is a feature-rich, Windows-based application offering fully-integrated point-of-sale, inventory control and accounting functionality. “

Matthews International (NASDAQ:MATW) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Matthews International Corporation is a designer, manufacturer and marketer principally of memorialization products & brand solutions. Memorialization products consist primarily of bronze memorials and other memorialization products, caskets and cremation equipment for the cemetery & funeral home industries. Brand solutions include graphics imaging products & services, marking products, & merchandising solutions. The Company’s products & services include cast bronze memorials & other memorialization products; caskets; cast & etched architectural products; cremation equipment & cremation- related products; mausoleums; brand management, printing plates, pre-press services, & imaging systems for the primary packaging & corrugated industries; marking equipment & consumables, & industrial automation products for identifying, tracking & conveying various consumer & industrial products, components & packaging containers; & merchandising display systems and marketing & design services. “

MB Financial (NASDAQ:MBFI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “MB Financial, Inc. is a bank holding company which conducts a commercial banking business through Manufacturers Bank. “

Merchants Bancorp (NASDAQ:MBIN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $23.00 target price on the stock. According to Zacks, “Merchants Bancorp is a diversified bank holding company. It provides multi-family housing and health care facility financing, mortgage warehousing, retail and correspondent residential mortgage banking, agricultural lending and traditional community banking services, through its subsidiaries. Merchants Bancorp is based in Carmel, United States. “

Medidata Solutions (NASDAQ:MDSO) was upgraded by analysts at Zacks Investment Research from a sell rating to a buy rating. Zacks Investment Research currently has $74.00 target price on the stock. According to Zacks, “Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies. “

Michelin (OTCMKTS:MGDDY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $33.00 target price on the stock. According to Zacks, “Compagnie Generale des Etablissements Michelin manufactures and sells tires for all kinds of vehicles, publishes maps and guides and operates a number of digital services. It manufactures and sells tires for cars, two-wheel vehicles, trucks, construction machinery, tractors and aircrafts. It also sells various car and bicycle accessories like pumps, manometers bicycle helmets, hubcaps, replacement components for tires and transport accessories. Other products sold by the company include protective clothing, table tennis rackets, shoe insoles along with many other items designed for road users. Compagnie Generale des Etablissements Michelin is based in Clermont-Ferrand, France. “

Morgan Sindall Group (LON:MGNS) had its buy rating reiterated by analysts at Peel Hunt. The firm currently has a GBX 1,600 ($22.91) price target on the stock.

M&T Bank (NYSE:MTB) had its buy rating reiterated by analysts at Jefferies Group LLC. They currently have a $207.00 target price on the stock.

Netflix (NASDAQ:NFLX) had its hold rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $312.00 target price on the stock.

Netflix (NASDAQ:NFLX) had its buy rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a $350.00 price target on the stock.

Nektar Therapeutics (NASDAQ:NKTR) had its buy rating reissued by analysts at Mizuho. Mizuho currently has a $103.00 price target on the stock. The analysts wrote, “We believe Keytruda’s data reinforces our thesis on Nektar. Assuming positive data at ASCO, we believe BMS would be inclined to make a bid for Nektar given its deteriorating market position relative to Merck.””

Olin (NYSE:OLN) had its buy rating reissued by analysts at Royal Bank of Canada. The firm currently has a $37.00 price target on the stock.

Porvair (LON:PRV) had its buy rating reiterated by analysts at Peel Hunt. They currently have a GBX 580 ($8.30) target price on the stock.

Pelatro (LON:PTRO) had its corporate rating reissued by analysts at FinnCap. FinnCap currently has a GBX 100 ($1.43) price target on the stock.

Shire (LON:SHP) had its outperform rating reissued by analysts at Royal Bank of Canada.

Shire (LON:SHP) had its buy rating reiterated by analysts at Deutsche Bank. They currently have a GBX 3,559 ($50.96) price target on the stock.

Westlake Chemical (NYSE:WLK) had its buy rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $130.00 target price on the stock.

Receive News & Ratings for Associated British Foods Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Associated British Foods and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply